483
Reproductive Technologies, Inc.Reproductive Technologies, Inc. – FDA 483, Aug 16, 2019
Record Details
An FDA inspection of Reproductive Technologies, Inc. in Berkeley, CA, revealed significant deficiencies in their human reproductive tissue operations. The firm failed to properly determine donor eligibility, adequately screen for communicable disease risks like HIV, Hepatitis B, Zika, and West Nile Virus, and maintain complete records for distributed semen. These issues indicate a serious lack of control over the safety and quality of their distributed HCT/Ps.
View Company Profile
ID · bee58ae9-e9bd-4050-81d0-da45f602ce72
Other documents for Reproductive Technologies, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.